Efrat Dotan News Today

Efrat Dotan, MD, discusses a retrospective study aiming to understand the needs of geriatric patients with gastroesophageal cancer.

Efrat Dotan, MD, discusses routine provider assessment vs the utility of geriatric assessment in geriatric patients with gastroesophageal disease.

Efrat Dotan, MD, discusses the use of geriatric function assessments in elderly patients with gastroesophageal cancer.

Older adults with gastric cancer tended to have better outcomes when they walked 2,500 steps per day or more.

PanCAN’s Scientific & Medical Advisory Board (SMAB) welcomes new leadership and members, representing the foremost expertise in the field of pancreatic cancer from institutions across the US.

Nonprofit’s Scientific and Medical Advisory Board Represented by Foremost Leaders in Pancreatic Cancer Field LOS ANGELES, Calif. – (July 18, [...] READ MORE

/PRNewswire/ -- The Pancreatic Cancer Action Network (PanCAN), a leading nonprofit in the fight against pancreatic cancer, proudly announces the addition of...

email article Treatment with pembrolizumab (Keytruda) improved survival for patients with microsatellite instability-high (MSI-H) gastric or gastroesophageal junction (GEJ) cancer, irrespective of the number of prior therapies, a retrospective analysis of three clinical trials suggested. The median overall survival (OS) with pembrolizumab-containing therapy was not reached in the MSI-H subgroup in any of the trials, which involved previously treated and untreated patients. Median progress...

NCCN Patient Advocacy Summit Emphasizes Treating Every Cancer Patient as an Individual Virtual #NCCNPolicy summit from the National Comprehensive Cancer Network explores how the needs and wishes of people with cancer can vary from group to group and person to person across all ages. News provided by Share this article Senator Chris Van Hollen (D-MD) and Congressman Buddy Carter (R-GA), which was streamed online. Every year, the NCCN Policy department invites people from across the oncology eco...